Ashkon Software



EGLT Stock - Egalet Corporation

EGLT Stock Chart

EGLT Profile

Egalet Corporation logo

Egalet Corporation (EGLT) is a specialty pharmaceutical company that focuses on developing and commercializing treatments for pain and other conditions. The company's primary product is Arymo ER, an extended-release morphine drug used for the management of pain. Egalet also develops other products using its proprietary technology platform, which is designed to create abuse-deterrent products that are more difficult to manipulate for non-medical purposes.

Egalet was founded in 2010 and is headquartered in Wayne, Pennsylvania. The company has a strong focus on research and development, with several drug candidates in various stages of clinical development. In addition to its proprietary technology platform, Egalet has also licensed technology from other companies to support its drug development efforts.

The company faces several challenges in the highly competitive pharmaceutical industry, including the need to gain regulatory approval for its products, establish a market presence, and compete with established players in the pain management market. Egalet has also faced financial challenges, with a history of losses and limited financial resources to support its research and development efforts.

Egalet's stock is traded on the OTC Markets Group under the ticker symbol EGLT. As with all OTC stocks, investors should exercise caution and conduct thorough research before making any investment


Copyright © 2000-2024, Ashkon Software LLC
Privacy Policy | Refund Policy | Disclaimer